Role of progesterone deficiency in the development of luteinizing hormone and androgen abnormalities in polycystic ovary syndrome

European Journal of Endocrinology

Volumn 135, Issue 3, 1996, Pages 335-339

  Fiad, Tarek M ^a   Cunningham, Sean K ^a   McKenna, T Joseph ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; ESTRONE; FOLLITROPIN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; PROGESTERONE; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

EID: 0029861045     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1350335     Document Type: Article

References (42)

1. Hull MGR. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1987;1:235-45
2. Stein IF, Leventhal ML. Amenorrhoea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181-91
3. McKenna TJ, Hayes F. Recent advances in the diagnosis and treatment of polycystic ovary syndrome. In: Recent advances in obstetrics and gynaecology. London: Churchill Livingstone. In press
4. Buyalos RP, Geffner ME, Bersch N, Judd HL, Watanabe RM, Bergman RN, et al. Insulin and insulin-like growth factor-I responsive in polycystic ovary syndrome. Fertil Steril 1992;57:796-803
5. Robinson, S, Rodin DA, Deacon AS, Wheeler MJ, Clayton RN. Which hormone tests for the diagnosis of polycystic ovary syndrome? Br J Obstet Gynecol 1992;99:232-8
6. Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 1995; 16:322-53
7. Franks S. Polycystic ovary syndrome. N Engl J Med 1995;333: 853-61
8. Lopez-Lopez E, Noguera MC, Fuente T, Parrilla JJ, Abad L. Response to clomiphene citrate in polycystic ovarian syndrome according to different LH:FSH ratio. Hum Reprod 1987;2:635-8
9. Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, et al. Gonadotropin-releasing hormone (GnRH) analogue suppression renders polycystic ovarian disease patients more susceptible to ovarian induction with pulsatile GnRH. J Clin Endocrinol Metal 1988;66:327-33
10. Kirschner MA, Zucker R, Jespersen D. Idiopathic hirsutism: an ovarian abnormality. N Engl J Med 1976;294:637-40
11. Loughlin T, Cunningham SK, Moore A, Culliton M, Smyth PPA, McKenna TJ. Adrenal abnormalities in polycystic ovary syndrome. J Clin Endocrinol Metab 1986;62:142-7
12. Rodin A, Thakkar H, Taylor N, Clayton R. Hyperandrogenism in polycystic ovary syndrome: evidence of dysregulation of 11β-hydroxysteroid dehydrogenase. N Engl J Med 1994;330:460-5
13. Zumoff B, Freeman R, Coupey S, Saenger P, Markowitz M, Kream J. A chronobiological abnormality in luteinizing hormone secretion in teenage girls with the polycystic-ovarian syndrome. N Engl J Med 1983;309:1206-9
14. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance independent of obesity, in polycystic ovary syndrome. Diabetes 1989;38:1165-74
15. Giudice LC. Insulin-like growth factors and ovarian follicular development. Endocr Rev 1992;13:641-69
16. Hague WM, Adams J, Rodda C, Brook CG, de Bruyn R, Grant DB, et al. The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clin Endocrinol (Oxf) 1990;33:501-10
17. Nelson DH. Cushing's syndrome. In: DeGroot LJ, editor. Endocrinology. 2nd ed. Philadelphia: WB Saunders, 1989: 1660-75
18. Dunaif A, Scully RE, Anderson RN, Chopin DS, Crowley Jr WF. The effects of continuous androgen secretion of the hypothalamic-pituitary axis in women: evidence from a luteinized thecoma of the ovary. J Clin Endocrinol Metab 1984;59:389-93
19. Petsos P, Ratcliffe WA, Anderson DC. Effects of medroxyprogesterone acetate in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1986;25:651-60
20. Blankstein J, Rabinovici J, Goldenberg M, Shaley J, Metha A, Serr D, et al. Changing pituitary sensitivity to follicular stimulating hormone and luteinizing hormone releasing hormone after induced ovulatory cycles and after anovulalion in patients with polycystic ovarian disease. J Clin Endocrinol Metab 1987;65: 1164-7
21. Eden JA, Place J, Carter GD, Alaghband-Zadeh J, Pawson ME. The role of chronic anovulation in the polycystic ovary syndrome: normalisation of sex hormone binding globulin levels after clomiphene-induced ovulation. Clin Endocrinol (Oxf) 1989; 30:323-32
22. Kettel LM, Rosoff SJ, Berga SL, Mortola JF, Yen SSC. Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome. Fertil Steril 1993;59:532-8
23. Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 1986;293:355-9
24. Montwill J, Igoe D, McKenna TJ. The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome. Steroids 1994;59:296-8
25. Rodbard D. Statistical quality control and routine data processing for radioimmunoassays and radioimmunometric assays. Clin Chem 1974;20:1255-70
26. Sequeira SJ, Loughlin T, Cunningham SK, Culliton MT, Hannon S, Heffrenan A, et al. Evaluation of an aldosterone radioimmunoassay: the renin-angiotensin-aldosterone axis as a function of sex and age. Ann Clin Biochem 1986;23:65-75
27. Abraham GE. Radioimmunoassay of plasma steroid hormones. In: Heftman E, editor. Modern methods of steroid analysis. New York: Academic Press, 1973;451-70
28. Cunningham SK, McKenna TJ. Evaluation of an immunoassay for plasma sex hormone binding globulin: comparison with steroid binding assay under physiological and pathological conditions. Ann Clin Biochem 1988;25:350-7
29. Cunningham SK, Loughlin T, Culliton M, McKenna TJ. Plasma sex hormone-binding globulin and androgen levels in the management of hirsute patients. Acta Endocrinol (Copenh) 1983;104:365-71
30. Veldhuis JD, Johnson ML. Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol 1986;250:E486-93
31. Urban RJ, Johnson ML, Veldhuis JD. In vivo biological validation and biophysical modelling of the sensitivity and positive accuracy of endocrine peak detection. I. The LH pulse signal. Endocrinology 1989;124:2541-7
32. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-7
33. Berga SL, Yen SSC. Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1989;30:177-84
34. Christman GM, Randolph JF, Kelch RP, Marshall JC. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovary disease. J Clin Endocrinol Metab 1991;72:1278-85
35. Kazer RR, Kessel B, Yen SSC. Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1987;65:233-6
36. Waldstreicher J, Santoro NF, Hall JE, Filicori M, Crowley WF. Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence of partial gonadotrope desensitisation. J Clin Endocrinol Metab 1988;66:165-72
37. Hall JE. Polycystic ovarian disease as a neuroendocrine disorder of the female reproductive axis. Endocrinol Metab Clin N Am 1993; 22:75-92
38. Berga SL, Guzick DS, Winters SJ. Increased luteinizing hormone and α subunit secretion in women with hyperandrogenic anovulation. J Clin Endocrinol Metab 1993;77:895-901
39. Homburg R, Weissglas L, Goldman J. Improved treatment of anovulation in polycystic ovarian disease utilising the effect of progesterone on the inappropriate gonadotropin release and clomiphene response. Hum Reprod 1988;3:285-8
40. McKenna TJ, Cunningham SK, Loughlin T. Ovarian oestradiol secretion is suppressed and LH-FSH ratio is elevated in common forms of amenorrhoea. In: Genazzani AR, Volpe A, Facchinetti F, editors. Research in gynaecology and endocrinology. Park Ridge, NJ: Parthenon Publishing, 1986:157-68
41. Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992;36:105-11
42. Guzick DS, Wing R, Smith D, Berga SL, Winters SJ. Endocrine consequences of weight loss in obese, hyperandrogenaemic, anovulatory women. Fertil Steril 1994;61:598-604